Aaron Freels
About Aaron Freels
Aaron Freels serves as the Director of Sales for the West Coast at Suvoda, where he has worked since 2024. He has a diverse background in sales and clinical trial management, with previous roles at companies such as Ferring Pharmaceuticals and LeadVenture™.
Current Role at Suvoda
Aaron Freels serves as the Director of Sales for the West Coast at Suvoda, a position he has held since 2024. In this role, he is responsible for leading sales initiatives and strategies in the West Coast region, focusing on enhancing client relationships and driving revenue growth. His tenure at Suvoda began in 2021 when he joined as a Senior Account Executive, where he contributed to the company's sales efforts for two years in Portland, Oregon.
Previous Experience in Sales
Before joining Suvoda, Aaron Freels accumulated extensive experience in sales across various industries. He worked as a Medical Device Sales Representative at Ferring Pharmaceuticals from 2014 to 2016 and at kaleo from 2017 to 2018. He also served as a Senior Account Executive at LeadVenture™ from 2018 to 2021. Earlier in his career, he held positions in advertising sales at Clear Channel Radio and Lamar Advertising, and as a Sales Representative at Wells Fargo Financial.
Educational Background
Aaron Freels studied at Portland State University - School of Business, where he earned a Master of Business Administration (MBA) with a focus on Business/Managerial Economics from 2018 to 2020. He also attended the University of Oregon, where he studied Business/Corporate Communications and Economics. His educational background provides a solid foundation for his career in sales and business management.
Expertise in Clinical Trials
Aaron Freels possesses specialized knowledge and expertise in managing clinical trials, particularly in areas such as Oncology, Cardiology, Cardiovascular, and Ophthalmology. He has experience in global site payments and compliance with the Physician Sunshine Act. His skills include Clinical Financial Analytics, Clinical Trial Retention & Compliance, and integrating Electronic Data Capture (EDC) with Electronic Healthcare Records (EHR). He is also skilled in utilizing CDISC's Study Data Tabulation Model (SDTM) for FDA submissions.